MAPS Bulletin Spring 2017: Vol 27, No. 1 Special Edition: Psychedelic Science

Download this entire issue or browse individual articles by title below.

Front CoverBack Cover
 Front Cover 
  Inside Front Cover 
1Table of Contents 
2From the Desk of Rick Doblin, Ph.D., MAPS Founder and Executive DirectorRick Doblin, Ph.D.
3Psychedelic Studies: Implications for Psychiatric Research and CarePaul Summergrad, M.D.
6A New Era for Psychedelic Medicine
Amanda Feilding
10Why We’re Donating $5 Million to MAPSDavid Bronner, CEO of Dr. Bronner’s, Board Member of MAPS
12Psychedelic Science 2017: Interview with Conference Director Brad BurgeWesley Thoricatha
14Community Forums at Psychedelic Science 2017: A Vibrant Dialogue Between Scientists and PractitionersBeatriz Caiuby Labate, PH.D.
15Sharing Our Stories: Psymposia at Psychedelic Science 2017Lex Pelger
17Towards Breakthrough Healing: A History and Overview of Clinical MDMA ResearchEmily Williams, M.D.
20Being Present for the Journey: Experiences of MDMA-Assisted TherapyKaren Diamond & John Saul
24 A Psychedelic Renaissance: Historical Reflections on the FutureErika Dyck, PH.D.
27Research Update: Phase 2 Clinical Trial of Marijuana for Symptoms of PTSD in U.S. VeteransMultidisciplinary Association for Psychedelic Studies (MAPS)
28Research Update: Psychedelic Group Therapy in SwitzerlandPeter Gasser, M.D.
30Heffter Research Institute: Psilocybin Research to Alleviate Suffering and Understand ConsciousnessDavid Nichols, Ph.D. & George Greer, M.D.
32Experience as Medicine: Insights from Studying Psychedelics and MusicMendel Kaelen
34 Understanding and Working with Difficult Psychedelic ExperiencesSara Gael, M.A.
36 Psychedelics and the Trauma of Daily InjusticeNatalie Lyla Ginsberg
38Psychedelic Justice: How Do We Repair
the Harms of Psychedelic Prohibition?
Jag Davies
40A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My LifeAyelet Waldman
44FUNDAMENTAL: Crowdfunding Psychedelic ResearchRodrigo Niño
 Back Cover